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diastolic dimension (r=.65) and age (r=.81). There was no correlation between BNP and 
LVEF or JH/LVOT. 
Conclusion: These data demonstrate elevated levels of BNP in patients with chronic AR 
and normal LV systolic function. Thus, even in patients who have no clinical evidence of 
cardiac decompensation, BNP levels may serve as a non-invasive marker of the valvular 
burden in a given patient, providing additional inexpensive and objective evidence of the 
severity of volume overload. These findings indicate that long-term prospective studies 
are warranted to determine the prognostic significance of BNP levels in patients with 
chronic AR. 
1085-135 Patho log ica l  F ibros is  in Aort ic  Regurg i tat ion Is 
Mediated by c-Jun/ATF-2 Complex Formation With 
cAMP Response Element  In Cardiac F ibroblsete 
Shareda L. Truter, Eungsuk Lee, Jennifer A. Lee, Phyllis G. Suplno, Jeffrey S. Borer, 
Weill Medical College of Cornel/Universi~ New York, New York. 
Background: We have shown that chronic aortic regurgitation (AR) causes myocardial 
fibrosis with excess matrix fibronectin (FN). Data suggest the SAPK/JNK pathway could 
modify FN gene expression by activating c-Jun/ATF-2 nuclear factors (nf) with complex 
formation between nf and the FN promoter. Methods: To test the role of this reaction in 
AR cardiac flbroblasts (CF), we assayed c-Jun/ATF-2 complex formation to FN cyclic 
AMP response element (FN-CRE) using electrophoretic mobility shifts in nuclear extracts 
of cultured CF from 5 nl NZW rabbits and 5 with chronic surgical AR (R fractions IF] 
=14%, 25%, 45%, 54%,>70%). Triplicate samples were prepared at passage 7. Nuclear 
extracts were incubated in DNA: protein binding buffer containing 32p-labeled double- 
stranded FN-CRE oligonucleotides. Samples were separated by PAGE; gels were dried 
and exposed to X-ray film for videodensitometry. Specific binding of c-Jun/ATF-2 to FN- 
CRE was verified by competition assays with non-radioactive FN-CRE and by cJun/ATF- 
2 antibody supershifts. Results: Increased complex formation to FN-CRE was seen in 5/ 
5 AR-CF lines (p=.03; See Table). 
CRE complex formation correlated with AR severity (r2=.26; p=.05). Conclusion: Chronic 
AR stimulates binding of c-Jun/ATF-2 to FN-CRE. Thus, increased FN expression by AR- 
CF may be mediated by increased c-Jun/ATF-2 complex formation to its promoter, acti- 
vating] transcription. 
Cell Pair %RF of AR Rel. c-Jun/ATF-2-FN-CRE Complex Increase (AR:nl) 
nil vs AR1 14 1.1:1.0 
hi2 vs AR2 25 2.0:1.0 
n13 vs AR3 45 1.3:1.0 
n14 vs AR4 54 1.2:1.0 
n15 vs AR5 >70 3.0:1.0 
1085-136 Impact  of  Veeodi lator  Use on Adverse Events in Chronic 
Severe Aortic Regurgitation 
Phyllis G. Supino, Jeffrev S. Borer, Clare A. Hochreiter, Edmund M. Herrold, Mary J. 
Roman, Richard B. Devereux, Paul Kligfield, Weill Medical College of Comell Universi~ 
New York, New York. 
Background: Vasodilating drugs (VDD) often are prescribed for asymptomatic pts with 
severe aortic regurgitation (AR) but impact of VDD on clinical outcomes in AR is 
unknown. Methods: To obtain this information we followed 83 consecutive asymptomatic 
unoperated pts with chronic severe AR and initially nl LV ejection fraction (EF) at rest (r) 
for 7±4 endpoint-free yrs. Pts were 81% male; age at study entry was 44±15 yrs. We 
used survival analysis to relate chronic use of VDD at study entry (ACE inhibitors: 8 pts 
[9.6%]; other VDD: in 3 pts [3.6%]) to survival (all cause death) and to cardiac event-free 
survival (events=cardiac death, subnl LVEF r or congestive symptoms). Drugs were pre- 
scdbed prophylactically by primary physicians, not per protocol or based on clinical 
decline. Univadate comparisons of Kaplan-Meyer survival curves and Cox model analy- 
ses were performed sequentially to evaluate the potential confounding influence of base- 
line radionuclide cineangiographic LVEF~ LVEF at peak exercise (ex) or change from r to 
ex, echocardiographic LV dimensions at diastole and systole, r and ex heart rates and 
blood pressures, gender, age, or chronic use of other cardiac drugs at study entry or dur- 
ing follow-up. Results: During follow-up, 5/83 pts (6.0%) died, 14 (16.9%) developed 
symptoms without subnl LVEF, and 9 (10.8%) developed subnl LVEF ± symptoms. Aver- 
age annual dsk of death was more than 4-fold greater among pts who had chronically 
used VDD (3.45%) than among those who had not (0.79%, p=.005). Average annual risk 
of cardiac events similarly was higher among pts who had chronically used VDD 
(13.79%) than among those who had not used VDD (average annual risk=3.75%, p=.01). 
No other variable confounded the observed association between VDD use and cardiac 
events (p=NS, all other variables). Conclusion: These findings suggest that chronic use 
of VDD may increase dsk for cardiac events among asymptomatic pts with chronic 
severe AR and initially nl LVEFr. Randomized clinical trials should be conducted to evalu- 
ate this association and, with it, the appropriateness of the widespread prophylactic use 
of VDD in AR. 
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1109-131 The Ef fect  o f  Ori f ice Shape on the  Normalized Velocity 
Distr ibut ion Method for the  Quant i f i cat ion  of  Mitral 
Regurg l tent  Or i f ice Area 
Dimitri Deserranng, Kathryn E. Richards, Nell L. Graenberg, James D. Thomas, Mario J. 
Garcia, The Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Recently, we proposed the normalized velocity distribution (NVD) method 
for the quantification of mitral valve regurgitation. Using computational fluid dynamics 
simulations, a relationship between the NVD along the centerline of the proximal conver- 
gence zone and normalized distance from the orifice was obtained. The regurgitant ori- 
fice area (ROA) can be estimated by non-lineer least square fitting using the NVD-model: 
V/Vp = 0.6 / (l+6.6*(r/eqrt(ROA))Al.6) where v is velocity from color M-mode (CMM), Vp is 
the peak velocity from continuous wave (CW) Doppler and r is the location along the cen- 
terline. 
Initial in-vitro validation with circular odfices showed very promising results, Therefore, 
the purpose of this study was to investigate the effect of orifice shape on the performance 
of this new model. 
Methods: CMM and CW Doppler images were obtained in an in-vitro model with various 
shaped odflces (width (w) by height (h) ratio from 1:1 to 1:10). Customized Labview code 
was developed to perform the nonlinear fitting of the Doppler data to the NVD model. 
Estimates of regurgitant orifice area were obtained and compared to the measured area 
to investigate the effect of the orifice shape. 
Results: ROA estimates for circular odfices (ratio 1:1, reference standard) were in close 
agreement with the measured area (y = 1.01x + 0.0003, r = 0.96, SE = 0.05cm2). Com- 
pared to the reference standard, an increase in the overestimation is observed with 
increasing ratio w/h. A linear correlation was found between the ratio w/h ix) and the per- 
centage of error (y) in the estimation of ROA (y = 10.6x - 14.2, r = 0.97). 
Conclusion: If the regurgitant orifice is circular, the ROA can be estimated with high 
accuracy using this method. However, an increasing error is made as the orifice 
becomes more elliptical in shape. 
1109-132 A Semiautomat ic  Inter-AUasing Distance Method for 
Quantifying Aortic Regurgitation Using Digital Color 
Doppler M-Mode Computation: In Vivo Study in a 
Chronic Animal Model  
Xiaokui Li, Michael Jones, Xiang-Ning Li, Arthur D. Zetts, Gordon K. Mack, Ikuo 
Hashimoto, Yoshiki Mori, Crispin H. Davies, David J. Sahn, Oregon Health & Science 
Univemi~ Portland, Oregon, NHLBI, Bethesda, Maryland. 
Background: The accuracy of quantifying aortic regurgitation using flow convergence or 
vena contracta methods is limited by the ambiguity in identifying orifice center and the 
low temporal resolution of color Doppler. We developed a semiautomated method that is 
based on the inter-eliasing distance from color M-mode imaging to overcome these limi- 
tations and improve the reproducibility and accuracy by reducing user operation. Meth- 
ods: The aortic valve was partially resected in 6 sheep prior to the study. Nineteen 
hemodynamic states (blood, nitoprusside and angiotensin administration) were studied in 
open chest sheep. Digital color M-mode data were obtained epicardially with a muitiplane 
TEE probe and compared with aortic and pulmonary electromagnetic (EM) flow meters. 
On an off-line workstation, a set of adjustable curved borders was positioned on the 
aliasing lines to derive the instant regurgitant volume and flow rate. The velocities at the 
aliasing lines and the inter-aliasing distances were identified automatically from the digi- 
tal data set without he need for the user to identify the orifice center using the algorithm 
employed in our custom program. Results: There was excellent correlation between 
regurgitant flow volume calculated by the M-mode method and EM results (r=0.97, 
y=l.03x - 0.87, p<0.001), there was also good correlation for peak flow rate (r= 0.92, 
P<0.001). Conclusions: This new color Doppler M-mode technique is reliable and 
reproducible for quantifying regurgitant flow. 
